Unlocking Unprecedented Matching Potential
Matches on what the therapeutic candidate does, not how it's filed.
A kinase inhibitor and a PROTAC on the same pathway get filed under the same drug class. They aren't the same asset. Moleculeo matches on mechanism, modality, indication, and stage, so you filter by what the molecule actually does across 240+ platforms, 280+ biobank cohorts, and hundreds of investors.
Smarter matching. Each failed match improves the next one.
Moleculeo takes your feedback, plus private data that never gets published, to sharpen each match, so what surfaces isn't just available but uniquely more knowledgeable than any off-the-shelf AI tool and always better than the prior match.
We rank a shortlist before you expose your asset.
See your top matches, with the rationale, before any IP disclosure. Ownership verification confirms the compound belongs to you, and contact details are shared only with mutual consent, so you can test the market with your IP and relationships protected.
The Five-Sided Marketplace
A match only works when all five sides fit. The right partner stalls without the right data and funding. Moleculeo connects all five, so the match surfaces by design, not luck.
Biotech
Turn your compound into something investable
Get vetted, door-opening introductions to investors and the AI platforms built for your exact mechanism - not another list to chase. A compound is fundable when it's matched to the right partner.
Platforms
Get matched to the compounds you're actually built for
Compound owners matched to your mechanism, modality, indication, and stage - qualified inbound, instead of fighting for the same pool at the same conferences.
Biobanks
From invisible to in-demand
Your cohorts get matched to the platforms and compound owners who need your exact patient population - outcomes and biomarker data most of all. Qualified matching, not another directory listing.
Pharma
Cut through the pitch fatigue
Score hundreds of inbound assets against your strategy, so you see which are worth a meeting - before your team burns days filtering them by hand. Your criteria and strategy stay private.
Venture Capital & Investors
Give every portfolio company a partner map
A structured view of the development partners matched to each portco's asset - AI platforms, biobanks, pharma, and funding. Systematic, pre-screened dealflow, not relationship-dependent sourcing.
Intelligent Matching, Simplified
Leverage AI-driven insights without the complexity. Browse pre-validated matches tailored to your specific criteria and visualize compatibility scores instantly.
We replace the guesswork of R&D partnering with a transparent, data-first marketplace.
Request accessPowered by World-Class Infrastructure
Frequently Asked Questions
Our Team
Built by deal-makers and platform architects with deep pharma, data science and technology expertise, scaling partnerships to billion-dollar outcomes.
Achim Plueckebaum
Nora Volger
Lorenz Mayr
